Apellis Pharmaceuticals, Inc. Share Price
APLS$26.91
-$1.14 (-4.08%) Last updated on 09 Sep, 2025 | 01:29 ISTApellis Pharmaceuticals, Inc. Stock Performance
Open $27.92 | Prev. Close $28.05 | Circuit Range N/A |
Day Range $26.68 - $27.98 | Year Range $16.11 - $41.92 | Volume 1,34,920 |
Average Traded $27.19 |
Apellis Pharmaceuticals, Inc. Share Price Chart
About Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops EMPAVELI to treat C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, hematopoietic stem cell transplantation-associated thrombotic microangiopathy, focal segmental glomerulosclerosis, and delayed graft function; and APL-3007, a small interfering RNA, or siRNA for the treatment of GA. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.
Apellis Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Sep-25 | $27.92 | $26.90 | +0.00% |
08-Sep-25 | $27.92 | $26.90 | -4.32% |
05-Sep-25 | $28.71 | $28.11 | -1.82% |
04-Sep-25 | $27.50 | $28.64 | +2.99% |
03-Sep-25 | $28.12 | $27.80 | -1.30% |
02-Sep-25 | $27.98 | $28.17 | +2.10% |
29-Aug-25 | $28.04 | $27.59 | -1.64% |
FAQs on Apellis Pharmaceuticals, Inc. Share Price
Can I buy Apellis Pharmaceuticals, Inc. shares in India?
What is the share price of Apellis Pharmaceuticals, Inc.?
What is the 5 year returns of Apellis Pharmaceuticals, Inc.?
What are the high & low stock price of Apellis Pharmaceuticals, Inc. today?
What is the 52-week high and low of Apellis Pharmaceuticals, Inc. stock?